Interventions for idiopathic intracranial hypertension

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Lueck, Christian J ^a   McIlwaine, Gawn G ^b  

^a CANBERRA HOSPITAL   (Australia)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Humans; Intracranial hypertension *therapy

Indexed keywords

ACETAZOLAMIDE; CARDIAC GLYCOSIDE; CORTICOSTEROID; GLYCEROL; OCTREOTIDE; TOPIRAMATE; VASOPRESSIN;

BRAIN VENTRICLE PERITONEUM SHUNT; CEREBROSPINAL FLUID PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURETIC THERAPY; EYE MOVEMENT DISORDER; FENESTRATION; HEADACHE; HUMAN; HYPERBARIC OXYGEN; INCIDENCE; INTRACRANIAL HYPERTENSION; LUMBAR PUNCTURE; NEUROIMAGING; OBESITY; OPTIC NERVE; OUTCOME ASSESSMENT; PAPILLEDEMA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SODIUM RESTRICTION; STENT; VISUAL IMPAIRMENT; WEIGHT REDUCTION;

EID: 77950177864     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003434.pub2     Document Type: Review

References (32)

1. Bynke 2004 {published data only} Bynke G, Zemack G, Bynke H, Romner B. Ventriculoperitoneal shunting for idiopathic intracranial hypertension. Neurology 2004; 63(7):1314-6.
2. Herzau 1998 {published data only} Herzau V, Baykal HE. Long-term results of optic nerve sheath fenestration in pseudotumor cerebri [Langzeitergebnisse nach optikusscheidenfensterung bei pseudotumor cerebri]. Klinische Monatsblatter fur Augenheilkunde 1998;213(3):154-60.
3. Johnson 1998 {published data only} * Johnson LN, Krohel GB, Madsen RW, March GA. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998;105(12):2313-7.
4. Owler 2003 {published data only} Owler BK, Parker G, Halmagyi GM, Dunne VG, Grinnell V, McDowell D, et al.Pseudotumor cerebri syndrome: Venous sinus obstruction and its treatment with stent placement. Journal of Neurosurgery 2003;98(5):1045-5.
5. Salman 2001 {published data only} * Salman MS, Kirkham FJ, MacGregor, DL. Idiopathic "benign" intracranial hypertension: case series and review. Journal of Child Neurology 2001;16(7):465-70.
6. Sesenna 1996 {published data only} Sesenna E, Monteverdi R, Gandolfi S, Nizzoli V. Optic nerve sheath decompression (perioptic meningectomy) through a lateral orbitotomy approach: Indications and technique. Rivista di Neurobiologia 1996;42(4):313-21.
7. Sugerman 1999 {published data only} * Sugerman HJ, Felton WL, Sismanis A, Kellum JM, DeMaria EJ, Sugerman EL. Gastric surgery for pseudotumor cerebri associated with severe obesity. Annals of Surgery 1999;229(5):634-40.
8. Sugerman 2001 {published data only} * Sugerman HJ, Felton III WL, Sismanis A, Saggi BH, Doty JM, Blocher C, et al.Continuous negative abdominal pressure device to treat pseudotumor cerebri. International Journal of Obesity 2001;25 (4):486-90.
9. Warman 2000 {published data only} * Warman R. Management of pseudotumor cerebri in children. International Pediatrics 2000;15(3):147-50.
10. Çelebisoy 2007 {published data only} Çelebisoy N, Gökçay F, Sirin H, Akyürekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurologica Scandinavica 2007;116(5): 322-7.
11. Corbett 1982 Corbett JJ, Savino PJ, Thompson HS, Kansu T, Schatz NJ, Orr LS, et al.Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Archives of Neurology 1982;39(8):461-74.
12. Corbett 1983 Corbett JJ, Mehta MP. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology 1983;33 (10):1386-8.
13. Durcan 1988 Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Archives of Neurology 1988;45(8):875-7.
14. Giuseffi 1991 Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 1991;41(2):239-44.
15. Glanville 2006 Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
16. Higgins 2008 Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
17. Ireland 1990 Ireland B, Corbett JJ, Wallace RB. The search for causes of idiopathic intracranial hypertension: A preliminary case-control study. Archives of Neurology 1990;47(3):315-20.
18. Johnston 1974a Johnston I, Paterson A. Benign intracranial hypertension. I. Diagnosis and prognosis. Brain 1974;97(2):289- 300.
19. Johnston 1974b Johnston I, Paterson A. Benign intracranial hypertension. II. CSF pressure and circulation. Brain 1974;97(2):301-12.
20. Lipton 1972 Lipton HL, Michelson PE. Pseudotumor cerebri syndrome without papilledema. JAMA 1972;220(12):1591-2.
21. Mathew 1996 Mathew NT, Ravishankar K, Sanin LC. Coexistence of migraine and idiopathic intracranial hypertension without papilloedema. Neurology 1996;46(5):1226-30.
22. Maxner 1987 Maxner CE, Freedman MI, Corbett JJ. Asymmetric papilledema and visual loss in pseudotumour cerebri. Canadian Journal of Neurological Sciences 1987;14(4):593-6.
23. Miller 1998 Miller NR. Papilledema. In: Miller NR, Newman NJ editor(s). Walsh & Hoyt's Clinical Neuro-Ophthalmology. 5. Baltimore: Williams & Wilkins, 1998:487-548.
24. Quincke 1897 Quincke H. [Über Meningitis serosa und verwandte Zustände]. Deutsche Zeitschrift fur Nervenheilkunde 1897;9:149-68.
25. Radhakrishnan 1993a Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O'Fallon WM. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minnesota, 1976 to 1990. Archives of Neurology 1993;50(1):78-80.
26. Radhakrishnan 1993b Radhakrishnan K, Thacker AK, Bohlaga NH, Maloo JC, Gerryo SE. Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. Journal of the Neurological Sciences 1993;116(1):18-28.
27. Radhakrishnan 1994 Radhakrishnan K, Ahlskog JE, Garrity JA, Kurland LT. Idiopathic intracranial hypertension. Mayo Clinic Proceedings 1994;69(2): 169-80.
28. Rowe 1998 Rowe FJ, Sarkies NJ. Assessment of visual function in idiopathic intracranial hypertension. A prospective study. Eye 1998;12(1): 111-8.
29. Scott 1997 Scott IU, Siatkowski RM, Eneyni M, Brodsky MC, Lam BL. Idiopathic intracranial hypertension in children and adolescents. American Journal of Ophthalmology 1997;124(2):253-5.
30. Sher 1983 Sher NA, Wirtschafter J, Shapiro SK, See C, Shapiro I. Unilateral papilledema in 'benign' intracranial hypertension (pseudotumor cerebri). JAMA 1983;250(17):2346-7.
31. Wall 1991 Wall M, George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991;114(Pt 1A):155-80.
32. Weisberg 1975 Weisberg LA. Benign intracranial hypertension. Medicine Analytical Reviews of General Medicine, Neurology, Psychiatry, Dermatology, and Pediatrics 1975;54(3):197-207.